Serum Institute seeks inclusion of Covovax on CoWIN as heter

The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and in the 7-11 age group on June 28, 2022, subject to certain conditions.

Related Keywords

India , Prakash Kumar Singh , Drug Administration , Serum Institute Of India , European Medicines Agency , World Health Organisation , Novavax Inc , Serum Institute , Drugs Controller General , Covovax , Covovax Vaccine , Covid Vaccine , Ovid Cases India , Cowin , Covid 19 Vaccine , Ndian Express News ,